Physician profile
Naresh Punjabi
NPI 1447297411
$6,702.62
in general payments reported to CMS, 2019-2025
15 companies · $3,987 in 2025
The $3,987 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.72 · 2021: $27.93 · 2022: $196 · 2023: $2,267 · 2024: $204 · 2025: $3,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,942 · Travel and Lodging: $1,365 · Food and Beverage: $1,090 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,942.00 |
| Travel and Lodging | $1,365.34 |
| Food and Beverage | $1,090.39 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,942.00 | 2025 | |
| Inspire Medical Systems, INC. | $1,829.08 | 2022-2023 | Inspire |
| Harmony Biosciences LLC | $385.82 | 2023-2024 | Wakix |
| Resmed Corp | $141.18 | 2023 | |
| 4dmedical USA INC | $139.99 | 2023 | Xv Lvas, Ct Lvas |
| Jazz Pharmaceuticals INC. | $90.68 | 2020-2024 | |
| Inogen, INC. | $76.20 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Baxter Healthcare | $52.73 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $22.93 | 2025 | Glassia |
| United Therapeutics Corporation | $22.01 | 2025 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Punjabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.